SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4v1d'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E7W_A_MTXA301_1 (PTERIDINE REDUCTASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN (Homo sapiens)	5 / 12	PRO D 41 LEU D 119 LEU D 18 LEU D 86 ASP D 90	None	1.14A	1e7wA-4v1dD: undetectable	1e7wA-4v1dD: 17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1J96_B_TESB904_1 (3ALPHA-HYDROXYSTEROI D DEHYDROGENASE TYPE 3)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 157 ILE E 215 GLU E 221 LEU E 179	None	0.91A	1j96B-4v1dE: undetectable	1j96B-4v1dE: 17.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5L_A_NIOA991_1 (NICOTINATE-NUCLEOTID E--DIMETHYLBENZIMIDA ZOLE PHOSPHORIBOSYLTRANSF ERASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN (Homo sapiens)	5 / 9	GLY D 117 LEU D 20 GLU D 6 ARG D 116 GLY D 8	None	1.30A	1l5lA-4v1dD: undetectable	1l5lA-4v1dD: 17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1L5M_A_NIOA991_1 (NICOTINATE-NUCLEOTID E--DIMETHYLBENZIMIDA ZOLE PHOSPHORIBOSYLTRANSF ERASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN (Homo sapiens)	5 / 9	GLY D 117 LEU D 20 GLU D 6 ARG D 116 GLY D 8	None	1.26A	1l5mA-4v1dD: undetectable	1l5mA-4v1dD: 17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1T88_A_CAMA1422_0 (CYTOCHROME P450-CAM)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens; Homo sapiens)	4 / 7	PHE D 111 GLY E 237 VAL D 50 ASP D 99	None	1.01A	1t88A-4v1dD: undetectable	1t88A-4v1dD: 14.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.09A	1zzrA-4v1dE: undetectable 1zzrB-4v1dE: undetectable	1zzrA-4v1dE: 14.73 1zzrB-4v1dE: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZR_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.08A	1zzrA-4v1dE: undetectable 1zzrB-4v1dE: undetectable	1zzrA-4v1dE: 14.73 1zzrB-4v1dE: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_A_H4BA760_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.07A	1zzuA-4v1dE: undetectable 1zzuB-4v1dE: undetectable	1zzuA-4v1dE: 14.73 1zzuB-4v1dE: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZZU_B_H4BB761_1 (NITRIC-OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.08A	1zzuA-4v1dE: undetectable 1zzuB-4v1dE: undetectable	1zzuA-4v1dE: 14.73 1zzuB-4v1dE: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CML_C_ZMRC3478_1 (NEURAMINIDASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 8	SER E 170 ASP E 233 SER E 166 SER E 165	None	1.12A	2cmlC-4v1dE: undetectable	2cmlC-4v1dE: 16.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CML_D_ZMRD4478_1 (NEURAMINIDASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 8	SER E 170 ASP E 233 SER E 166 SER E 165	None	1.12A	2cmlD-4v1dE: undetectable	2cmlD-4v1dE: 16.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OLD_B_IPHB2001_0 (BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens; Homo sapiens)	4 / 7	TYR D 95 TYR E 176 PRO E 184 TYR E 227	None	0.47A	2oldA-4v1dD: 13.6 2oldB-4v1dD: 13.8	2oldA-4v1dD: 19.28 2oldB-4v1dD: 19.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OLD_B_IPHB2001_0 (BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens; Homo sapiens)	5 / 7	TYR E 176 HIS E 178 PRO E 184 TYR E 227 TYR D 95	None	0.49A	2oldA-4v1dE: 20.0 2oldB-4v1dE: 20.2	2oldA-4v1dE: 33.19 2oldB-4v1dE: 33.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OMB_D_IPHD2002_0 (BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	TYR E 176 HIS E 178 PRO E 184 TYR E 227	None	0.40A	2ombC-4v1dE: 19.7 2ombD-4v1dE: 19.9	2ombC-4v1dE: 33.19 2ombD-4v1dE: 33.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OMB_D_IPHD2002_0 (BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens; Homo sapiens)	4 / 7	TYR E 176 HIS E 178 PRO E 184 TYR D 95	None	0.78A	2ombC-4v1dE: 19.7 2ombD-4v1dE: 19.9	2ombC-4v1dE: 33.19 2ombD-4v1dE: 33.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEY_B_EV1B1771_1 (CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 8	LEU E 179 VAL E 248 ILE E 215 PHE E 202	None	0.89A	2weyB-4v1dE: undetectable	2weyB-4v1dE: 17.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZI9_A_CL9A401_2 (DEOXYCYTIDINE KINASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	3 / 3	ASP D 99 PHE D 111 LEU E 186	None	0.72A	2zi9A-4v1dD: undetectable	2zi9A-4v1dD: 18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.11A	3dqrA-4v1dE: undetectable 3dqrB-4v1dE: undetectable	3dqrA-4v1dE: 14.76 3dqrB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DQR_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.15A	3dqrA-4v1dE: undetectable 3dqrB-4v1dE: undetectable	3dqrA-4v1dE: 14.76 3dqrB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EEY_C_SAMC300_0 (PUTATIVE RRNA METHYLASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	5 / 12	GLY E 237 ASP E 233 GLY E 241 GLN E 145 ASN E 171	None	1.14A	3eeyC-4v1dE: undetectable	3eeyC-4v1dE: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EEY_D_SAMD300_0 (PUTATIVE RRNA METHYLASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	5 / 12	GLY E 237 ASP E 233 GLY E 241 GLN E 145 ASN E 171	None	1.14A	3eeyD-4v1dE: undetectable	3eeyD-4v1dE: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EEY_E_SAME300_0 (PUTATIVE RRNA METHYLASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	5 / 12	GLY E 237 ASP E 233 GLY E 241 GLN E 145 ASN E 171	None	1.13A	3eeyE-4v1dE: undetectable	3eeyE-4v1dE: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EEY_F_SAMF300_0 (PUTATIVE RRNA METHYLASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	5 / 12	GLY E 237 ASP E 233 GLY E 241 GLN E 145 ASN E 171	None	1.11A	3eeyF-4v1dE: undetectable	3eeyF-4v1dE: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EEY_H_SAMH300_0 (PUTATIVE RRNA METHYLASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	5 / 12	GLY E 237 ASP E 233 GLY E 241 GLN E 145 ASN E 171	None	1.13A	3eeyH-4v1dE: undetectable	3eeyH-4v1dE: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EEY_I_SAMI300_0 (PUTATIVE RRNA METHYLASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	5 / 12	GLY E 237 ASP E 233 GLY E 241 GLN E 145 ASN E 171	None	1.13A	3eeyI-4v1dE: undetectable	3eeyI-4v1dE: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EEY_J_SAMJ300_0 (PUTATIVE RRNA METHYLASE)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	5 / 12	GLY E 237 ASP E 233 GLY E 241 GLN E 145 ASN E 171	None	1.10A	3eeyJ-4v1dE: undetectable	3eeyJ-4v1dE: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.07A	3jx2A-4v1dE: undetectable 3jx2B-4v1dE: undetectable	3jx2A-4v1dE: 14.76 3jx2B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX2_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.07A	3jx2A-4v1dE: undetectable 3jx2B-4v1dE: undetectable	3jx2A-4v1dE: 14.76 3jx2B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.09A	3jx3A-4v1dE: undetectable 3jx3B-4v1dE: undetectable	3jx3A-4v1dE: 14.76 3jx3B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.06A	3jx3A-4v1dE: undetectable 3jx3B-4v1dE: undetectable	3jx3A-4v1dE: 14.76 3jx3B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.09A	3jx4A-4v1dE: undetectable 3jx4B-4v1dE: undetectable	3jx4A-4v1dE: 14.76 3jx4B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.06A	3jx5A-4v1dE: undetectable 3jx5B-4v1dE: undetectable	3jx5A-4v1dE: 14.76 3jx5B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX5_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.08A	3jx5A-4v1dE: undetectable 3jx5B-4v1dE: undetectable	3jx5A-4v1dE: 14.76 3jx5B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.03A	3jx6A-4v1dE: undetectable 3jx6B-4v1dE: undetectable	3jx6A-4v1dE: 14.76 3jx6B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JX6_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.03A	3jx6A-4v1dE: undetectable 3jx6B-4v1dE: undetectable	3jx6A-4v1dE: 14.76 3jx6B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.03A	3nljA-4v1dE: undetectable 3nljB-4v1dE: undetectable	3nljA-4v1dE: 14.76 3nljB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLJ_B_H4BB761_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.04A	3nljA-4v1dE: undetectable 3nljB-4v1dE: undetectable	3nljA-4v1dE: 14.76 3nljB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.05A	3nlpA-4v1dE: undetectable 3nlpB-4v1dE: undetectable	3nlpA-4v1dE: 14.76 3nlpB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLP_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.09A	3nlpA-4v1dE: undetectable 3nlpB-4v1dE: undetectable	3nlpA-4v1dE: 14.76 3nlpB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 8	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.00A	3nlqA-4v1dE: undetectable 3nlqB-4v1dE: undetectable	3nlqA-4v1dE: 14.76 3nlqB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLQ_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.01A	3nlqA-4v1dE: undetectable 3nlqB-4v1dE: undetectable	3nlqA-4v1dE: 14.76 3nlqB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLR_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.03A	3nlrA-4v1dE: undetectable 3nlrB-4v1dE: undetectable	3nlrA-4v1dE: 14.76 3nlrB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLR_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 8	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.05A	3nlrA-4v1dE: undetectable 3nlrB-4v1dE: undetectable	3nlrA-4v1dE: 14.76 3nlrB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.10A	4cx3A-4v1dE: undetectable 4cx3B-4v1dE: undetectable	4cx3A-4v1dE: 14.76 4cx3B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX3_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.08A	4cx3A-4v1dE: undetectable 4cx3B-4v1dE: undetectable	4cx3A-4v1dE: 14.76 4cx3B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.11A	4cx4A-4v1dE: undetectable 4cx4B-4v1dE: undetectable	4cx4A-4v1dE: 14.76 4cx4B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CX4_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.08A	4cx4A-4v1dE: undetectable 4cx4B-4v1dE: undetectable	4cx4A-4v1dE: 14.76 4cx4B-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QZT_A_RTLA201_0 (RETINOL-BINDING PROTEIN 2)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens; Homo sapiens)	5 / 12	ILE E 188 GLN E 145 TYR E 226 GLN D 39 LEU D 45	None	1.24A	4qztA-4v1dE: undetectable	4qztA-4v1dE: 15.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADD_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.00A	5addA-4v1dE: undetectable 5addB-4v1dE: undetectable	5addA-4v1dE: 14.76 5addB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ADE_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	0.98A	5adeA-4v1dE: undetectable 5adeB-4v1dE: undetectable	5adeA-4v1dE: 14.76 5adeB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_A_H4BA760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	VAL E 248 ARG E 201 VAL E 157 GLU E 223	None	1.08A	5g0pA-4v1dE: undetectable 5g0pB-4v1dE: undetectable	5g0pA-4v1dE: 14.76 5g0pB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G0P_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN (Homo sapiens)	4 / 7	GLU E 223 VAL E 248 ARG E 201 VAL E 157	None	1.08A	5g0pA-4v1dE: undetectable 5g0pB-4v1dE: undetectable	5g0pA-4v1dE: 14.76 5g0pB-4v1dE: 14.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CJK_C_ACTC301_0 (IMMUNOGLOBULIN FAB LIGHT CHAIN)	4v1d	SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN (Homo sapiens)	4 / 4	VAL D 50 GLY D 33 ASP D 99 ASP D 102	None	1.30A	6cjkC-4v1dD: 14.9	6cjkC-4v1dD: 20.66

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1E7W_A_MTXA301_1","PTERIDINE REDUCTASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN","Homo sapiens",5,"PRO D  41;LEU D 119;LEU D  18;LEU D  86;ASP D  90","None","1.14A","1e7wA-4v1dD:undetectable","1e7wA-4v1dD:17.53"],["1J96_B_TESB904_1","3ALPHA-HYDROXYSTEROID DEHYDROGENASE TYPE 3","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 157;ILE E 215;GLU E 221;LEU E 179","None","0.91A","1j96B-4v1dE:undetectable","1j96B-4v1dE:17.26"],["1L5L_A_NIOA991_1","NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN","Homo sapiens",5,"GLY D 117;LEU D  20;GLU D   6;ARG D 116;GLY D   8","None","1.30A","1l5lA-4v1dD:undetectable","1l5lA-4v1dD:17.20"],["1L5M_A_NIOA991_1","NICOTINATE-NUCLEOTIDE--DIMETHYLBENZIMIDAZOLE PHOSPHORIBOSYLTRANSFERASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN","Homo sapiens",5,"GLY D 117;LEU D  20;GLU D   6;ARG D 116;GLY D   8","None","1.26A","1l5mA-4v1dD:undetectable","1l5mA-4v1dD:17.20"],["1T88_A_CAMA1422_0","CYTOCHROME P450-CAM","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN;SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens;Homo sapiens",4,"PHE D 111;GLY E 237;VAL D  50;ASP D  99","None","1.01A","1t88A-4v1dD:undetectable","1t88A-4v1dD:14.25"],["1ZZR_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.09A","1zzrA-4v1dE:undetectable;1zzrB-4v1dE:undetectable","1zzrA-4v1dE:14.73;1zzrB-4v1dE:14.73"],["1ZZR_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.08A","1zzrA-4v1dE:undetectable;1zzrB-4v1dE:undetectable","1zzrA-4v1dE:14.73;1zzrB-4v1dE:14.73"],["1ZZU_A_H4BA760_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.07A","1zzuA-4v1dE:undetectable;1zzuB-4v1dE:undetectable","1zzuA-4v1dE:14.73;1zzuB-4v1dE:14.73"],["1ZZU_B_H4BB761_1","NITRIC-OXIDE SYNTHASE, BRAIN;NITRIC-OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.08A","1zzuA-4v1dE:undetectable;1zzuB-4v1dE:undetectable","1zzuA-4v1dE:14.73;1zzuB-4v1dE:14.73"],["2CML_C_ZMRC3478_1","NEURAMINIDASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"SER E 170;ASP E 233;SER E 166;SER E 165","None","1.12A","2cmlC-4v1dE:undetectable","2cmlC-4v1dE:16.20"],["2CML_D_ZMRD4478_1","NEURAMINIDASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"SER E 170;ASP E 233;SER E 166;SER E 165","None","1.12A","2cmlD-4v1dE:undetectable","2cmlD-4v1dE:16.20"],["2OLD_B_IPHB2001_0","BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN;SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens;Homo sapiens",4,"TYR D  95;TYR E 176;PRO E 184;TYR E 227","None","0.47A","2oldA-4v1dD:13.6;2oldB-4v1dD:13.8","2oldA-4v1dD:19.28;2oldB-4v1dD:19.28"],["2OLD_B_IPHB2001_0","BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN;SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens;Homo sapiens",5,"TYR E 176;HIS E 178;PRO E 184;TYR E 227;TYR D  95","None","0.49A","2oldA-4v1dE:20.0;2oldB-4v1dE:20.2","2oldA-4v1dE:33.19;2oldB-4v1dE:33.19"],["2OMB_D_IPHD2002_0","BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"TYR E 176;HIS E 178;PRO E 184;TYR E 227","None","0.40A","2ombC-4v1dE:19.7;2ombD-4v1dE:19.9","2ombC-4v1dE:33.19;2ombD-4v1dE:33.19"],["2OMB_D_IPHD2002_0","BENCE JONES KWR PROTEIN - IMMUNOGLOBULIN LIGHT CHAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN;SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens;Homo sapiens",4,"TYR E 176;HIS E 178;PRO E 184;TYR D  95","None","0.78A","2ombC-4v1dE:19.7;2ombD-4v1dE:19.9","2ombC-4v1dE:33.19;2ombD-4v1dE:33.19"],["2WEY_B_EV1B1771_1","CAMP AND CAMP-INHIBITED CGMP 3', 5'-CYCLIC PHOSPHODIESTERASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"LEU E 179;VAL E 248;ILE E 215;PHE E 202","None","0.89A","2weyB-4v1dE:undetectable","2weyB-4v1dE:17.00"],["2ZI9_A_CL9A401_2","DEOXYCYTIDINE KINASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN;SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",3,"ASP D  99;PHE D 111;LEU E 186","None","0.72A","2zi9A-4v1dD:undetectable","2zi9A-4v1dD:18.64"],["3DQR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.11A","3dqrA-4v1dE:undetectable;3dqrB-4v1dE:undetectable","3dqrA-4v1dE:14.76;3dqrB-4v1dE:14.76"],["3DQR_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.15A","3dqrA-4v1dE:undetectable;3dqrB-4v1dE:undetectable","3dqrA-4v1dE:14.76;3dqrB-4v1dE:14.76"],["3EEY_C_SAMC300_0","PUTATIVE RRNA METHYLASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",5,"GLY E 237;ASP E 233;GLY E 241;GLN E 145;ASN E 171","None","1.14A","3eeyC-4v1dE:undetectable","3eeyC-4v1dE:22.89"],["3EEY_D_SAMD300_0","PUTATIVE RRNA METHYLASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",5,"GLY E 237;ASP E 233;GLY E 241;GLN E 145;ASN E 171","None","1.14A","3eeyD-4v1dE:undetectable","3eeyD-4v1dE:22.89"],["3EEY_E_SAME300_0","PUTATIVE RRNA METHYLASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",5,"GLY E 237;ASP E 233;GLY E 241;GLN E 145;ASN E 171","None","1.13A","3eeyE-4v1dE:undetectable","3eeyE-4v1dE:22.89"],["3EEY_F_SAMF300_0","PUTATIVE RRNA METHYLASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",5,"GLY E 237;ASP E 233;GLY E 241;GLN E 145;ASN E 171","None","1.11A","3eeyF-4v1dE:undetectable","3eeyF-4v1dE:22.89"],["3EEY_H_SAMH300_0","PUTATIVE RRNA METHYLASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",5,"GLY E 237;ASP E 233;GLY E 241;GLN E 145;ASN E 171","None","1.13A","3eeyH-4v1dE:undetectable","3eeyH-4v1dE:22.89"],["3EEY_I_SAMI300_0","PUTATIVE RRNA METHYLASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",5,"GLY E 237;ASP E 233;GLY E 241;GLN E 145;ASN E 171","None","1.13A","3eeyI-4v1dE:undetectable","3eeyI-4v1dE:22.89"],["3EEY_J_SAMJ300_0","PUTATIVE RRNA METHYLASE","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",5,"GLY E 237;ASP E 233;GLY E 241;GLN E 145;ASN E 171","None","1.10A","3eeyJ-4v1dE:undetectable","3eeyJ-4v1dE:22.89"],["3JX2_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.07A","3jx2A-4v1dE:undetectable;3jx2B-4v1dE:undetectable","3jx2A-4v1dE:14.76;3jx2B-4v1dE:14.76"],["3JX2_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.07A","3jx2A-4v1dE:undetectable;3jx2B-4v1dE:undetectable","3jx2A-4v1dE:14.76;3jx2B-4v1dE:14.76"],["3JX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.09A","3jx3A-4v1dE:undetectable;3jx3B-4v1dE:undetectable","3jx3A-4v1dE:14.76;3jx3B-4v1dE:14.76"],["3JX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.06A","3jx3A-4v1dE:undetectable;3jx3B-4v1dE:undetectable","3jx3A-4v1dE:14.76;3jx3B-4v1dE:14.76"],["3JX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.09A","3jx4A-4v1dE:undetectable;3jx4B-4v1dE:undetectable","3jx4A-4v1dE:14.76;3jx4B-4v1dE:14.76"],["3JX5_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.06A","3jx5A-4v1dE:undetectable;3jx5B-4v1dE:undetectable","3jx5A-4v1dE:14.76;3jx5B-4v1dE:14.76"],["3JX5_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.08A","3jx5A-4v1dE:undetectable;3jx5B-4v1dE:undetectable","3jx5A-4v1dE:14.76;3jx5B-4v1dE:14.76"],["3JX6_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.03A","3jx6A-4v1dE:undetectable;3jx6B-4v1dE:undetectable","3jx6A-4v1dE:14.76;3jx6B-4v1dE:14.76"],["3JX6_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.03A","3jx6A-4v1dE:undetectable;3jx6B-4v1dE:undetectable","3jx6A-4v1dE:14.76;3jx6B-4v1dE:14.76"],["3NLJ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.03A","3nljA-4v1dE:undetectable;3nljB-4v1dE:undetectable","3nljA-4v1dE:14.76;3nljB-4v1dE:14.76"],["3NLJ_B_H4BB761_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.04A","3nljA-4v1dE:undetectable;3nljB-4v1dE:undetectable","3nljA-4v1dE:14.76;3nljB-4v1dE:14.76"],["3NLP_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.05A","3nlpA-4v1dE:undetectable;3nlpB-4v1dE:undetectable","3nlpA-4v1dE:14.76;3nlpB-4v1dE:14.76"],["3NLP_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.09A","3nlpA-4v1dE:undetectable;3nlpB-4v1dE:undetectable","3nlpA-4v1dE:14.76;3nlpB-4v1dE:14.76"],["3NLQ_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.00A","3nlqA-4v1dE:undetectable;3nlqB-4v1dE:undetectable","3nlqA-4v1dE:14.76;3nlqB-4v1dE:14.76"],["3NLQ_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.01A","3nlqA-4v1dE:undetectable;3nlqB-4v1dE:undetectable","3nlqA-4v1dE:14.76;3nlqB-4v1dE:14.76"],["3NLR_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.03A","3nlrA-4v1dE:undetectable;3nlrB-4v1dE:undetectable","3nlrA-4v1dE:14.76;3nlrB-4v1dE:14.76"],["3NLR_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.05A","3nlrA-4v1dE:undetectable;3nlrB-4v1dE:undetectable","3nlrA-4v1dE:14.76;3nlrB-4v1dE:14.76"],["4CX3_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.10A","4cx3A-4v1dE:undetectable;4cx3B-4v1dE:undetectable","4cx3A-4v1dE:14.76;4cx3B-4v1dE:14.76"],["4CX3_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.08A","4cx3A-4v1dE:undetectable;4cx3B-4v1dE:undetectable","4cx3A-4v1dE:14.76;4cx3B-4v1dE:14.76"],["4CX4_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.11A","4cx4A-4v1dE:undetectable;4cx4B-4v1dE:undetectable","4cx4A-4v1dE:14.76;4cx4B-4v1dE:14.76"],["4CX4_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.08A","4cx4A-4v1dE:undetectable;4cx4B-4v1dE:undetectable","4cx4A-4v1dE:14.76;4cx4B-4v1dE:14.76"],["4QZT_A_RTLA201_0","RETINOL-BINDING PROTEIN 2","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN;SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens;Homo sapiens",5,"ILE E 188;GLN E 145;TYR E 226;GLN D  39;LEU D  45","None","1.24A","4qztA-4v1dE:undetectable","4qztA-4v1dE:15.82"],["5ADD_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.00A","5addA-4v1dE:undetectable;5addB-4v1dE:undetectable","5addA-4v1dE:14.76;5addB-4v1dE:14.76"],["5ADE_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","0.98A","5adeA-4v1dE:undetectable;5adeB-4v1dE:undetectable","5adeA-4v1dE:14.76;5adeB-4v1dE:14.76"],["5G0P_A_H4BA760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"VAL E 248;ARG E 201;VAL E 157;GLU E 223","None","1.08A","5g0pA-4v1dE:undetectable;5g0pB-4v1dE:undetectable","5g0pA-4v1dE:14.76;5g0pB-4v1dE:14.76"],["5G0P_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN","Homo sapiens",4,"GLU E 223;VAL E 248;ARG E 201;VAL E 157","None","1.08A","5g0pA-4v1dE:undetectable;5g0pB-4v1dE:undetectable","5g0pA-4v1dE:14.76;5g0pB-4v1dE:14.76"],["6CJK_C_ACTC301_0","IMMUNOGLOBULIN FAB LIGHT CHAIN","4v1d","SINGLE CHAIN ANTIBODY FRAGMENT RU1, HEAVY CHAIN","Homo sapiens",4,"VAL D  50;GLY D  33;ASP D  99;ASP D 102","None","1.30A","6cjkC-4v1dD:14.9","6cjkC-4v1dD:20.66"]]